Literaturverzeichnis

Akira, 1990: Akira, S; Isshiki, H et al. A nuclear factor for IL-6 expression (NF-IL6) is a member of a C/EBP family. Embo J. 1990, 9 (6), 1897-906

Aman, 1997: Aman, M. J.; Leonard, W. J. Cytokine signaling: cytokine-inducible signaling inhibitors. Curr Biol. 1997, 7 (12), R784-8

Asai, 2000: Asai, S; Saito, Y; et al. The heart is a source of circulating cardiotrophin-1in humans. Biochem Biophys Res Commun. 2000, 279(2), 320-3

Baig, 1998: Baig, M. K.; Goldman, J. H.; et al. Familial dilated cardiomyopathy: cardiac abnormalities are common in asymptomatic relatives and may represent early disease. J Am Coll Cardiol. 1998, 31(1), 195-201

Benigni, 1996: Benigni, F; Sacco, S; et al. Cardiotrophin-1 inhibits tumor necrosis factor production in the heart and serum of lipopolysaccharide-treated mice in vitro in mouse blood cells. Am J Pathol. 1996, 149, 1847-1850

Betz, 1998: Betz, U. A. K; Bloch, W; et al. Postnatally induced inactivation of gp130 in mice results in neurological, cardiac, hematopoietic, immunological, hepatic, and pulmonary defects. J Exp Med. 1998, 188(10), 1955-65

Birnboim, 1979: Birnboim, H. C; Doly, J. A rapid alkaline extraction procedure for screening recombinant plasmid DNA. Nucl Acids Res. 1979, 7(6), 1513-23

Blair, 2001: Blair, E; Redwood, C; et al. Mutations in the gamma (2) subunit of AMP-activated protein kinase cause familial hypertrophic cardiomyopathy: evidence for the central role of energy compromise in disease pathogenesis. Hum Mol Genet. 2001, 10(11), 1215-1220

Bowles, 1996: Bowles, K. R; Gajarski, R; et al. Gene mapping of familial autosomal dominant dilated cardiomyopathy to chromosome 10q21-23. J Clin Invest. 1996, 98(6), 1355-60

Braunwald, 1997: Braunwald, E. Heart disease: A textbook of cardiovascular medicine. W. B. Saunders Company, 1997

Budowle, 1991: Budowle, B; Chakraborty, R; et al. Analysis of the VNTR locus D1S80 by the PCR followed by high-resolution PAGE. Am J Hum Genet. 1991, 48(1), 137-44

Chandrasekar, 1996: Chandrasekar, B; Melby, P. C; et al. Induction of proinflammatory cytokine expression in experimental acute Chagasic cardiomyopathy. Biochem Biophys Res Commun. 1996, 223(2), 365-71

Chandrasekar, 1998: Chandrasekar, B; Melby, P. C; et al. Overexpression of cardiotrophin-1 and gp130 during experimental acute Chagasic cardiomyopathy. Immunol Lett. 1998, 61(2-3), 89-95

Chen, 1999: Chen, J; Chien, K. R. Complexity in simplicity: monogenic disorders and complex cardiomyopathies J Clin Invest. 1999, 103(11), 1483-5

Chevalier, 1996: Chevalier, S; Fourcin, M; et al. Interleukin-6 family of cytokines induced activation of different functional sites expressed by gp130 transducing protein. J Biol Chem. 1996, 271(25), 14764-72

Ciapponi, 1995: Ciapponi, L; Graziani, R; et al. Definition of a composite binding site for gp130 in human interleukin-6. J Biol Chem. 1995, 270(52), 31249-54


[Seite 100↓]

Codd, 1989: Codd, MB; Sugrue, DD; et al. Epidemiology of idiopathic dilated and hypertrophic cardiomyopathy: a population based study in Olmsted County, Minnesota, 1975-1984. Circulation. 1989, 80 5, 64-572

Colucci, 1996: Colucci, W. S. Apoptosis in the heart (editorial comment). N Engl J Med. 1996, 335(16), 1224-6

Condie, 1993: Condie, A; Eeles, R; et al. Detection of point mutations in the p53 gene: comparison of single-strand conformation polymorphism, constant denaturant gel electrophoresis, and hydroxylamine and osmium tetroxide techniques. Hum Mut. 1993, 2(1), 58-66

Cooper, 1984: Cooper, D; Schmidtke, J. DNA restriction fragment length polymorphisms and heterozygosity in the human genome. Hum Genet. 1984, 66(1), 1-16

Courey, 1989: Courey, A. J; Holtzman, D. A; et al. Synergistic activation by the glutamine-rich domains of human transcription factor Sp1. Cell. 1989, 59(5), 827-36

Craig, 2001: Craig, R; Wagner, M; et al. The cytoprotective effects of the glycoprotein 130 receptor-coupled cytokine, cardiotrophin-1, require activation of NF-kappa B. J Biol Chem. 2001, 276(40), 37621-9

D´Adamo, 1997: D´Adamo, P; Fassone, L; et al. The X-linked gene G4.5 is responsible for different infantile dilated cardiomyopathies. Am J Hum Genet. 1997, 61(4), 862-7

de Meeus, 1995: de Meeus, A. S. An isolated cardiac conduction disease maps to chromosome 19q. Circ Res. 1995, 77 7, 35-740

Durand, 1995: Durand, J. B; Abchee, A. B; et al. Molecular and clinical aspects of inherited cardiomyopathies. Ann Med. 1995, 27(3), 311-7

Eiken, 1991: Eiken, H. G; Odland, E; et al. Application of natural and amplification created restriction sites for the diagnosis of PKU mutations. Nucleic Acids Res. 1991, 19(7), 1427-30

Erdmann, 1998: Erdmann, J; Hassfeld, S; et al. Cloning and characterization of the 5´-flanking region of the human Cardiotrophin-1 gene. Biochem Biophys Res Commun. 1998, 244, 494-497

Erdmann, 2000: Erdmann, J; Hassfeld, S; et al. Genetic variants in the promoter (g983G>T) and coding region (A92T) of the human cardiotrophin-1 gene (CTF1) in patients with dilated cardiomyopathy. Hum Mut. 2000, 16(5), 448

Evans, 1988: Evans, T; Reitman, M; et al. An erythrocyte-specific DNA-binding factor recognizes a regulatory sequence common to all chicken globin genes. Proc Natl Acad Sci U S A. 1988, 85(16), 5976-80

Fatkin, 1999: Fatkin, D; MacRae, C; et al. Missense mutations in the rod domain of the lamin A/C gene as causes of dilated cardiomyopathy and conduction-system disease. N Engl J Med. 1999, 341(23), 1715-24

Fentzke, 1998: Fentzke, R. C; Korcarz, C. E; et al. Dilated cardiomyopathy in transgenic mice expressing a dominant-negative CREB transcription factor in the heart. J Clin Invest. 1998, 101(11), 2415-26

Franz, 1995: Franz, W. M; Cremer M; et al. X-linked dilated cardiomyopathy. Novel mutation of the dystrophin gene. Ann N Y Acad Sci. 1995, 752, 470-91

Freeman, 2001: Freeman, K; Colon-Rivera, C; et al. Progression from hypertrophic to dilated cardiomyopathy in mice that express a mutant myosin transgene. Am J Physiol Heart Circ Physiol. 2001, 280(1), H151-9

Fuchs, 2000: Fuchs, M; Drexler, H; et al. Pathophysiology of chronic heart failure. Internist (Berl). 2000, 41(2 Pt1), 93-104

Fukuzawa, 2000: Fukuzawa, J; Booz, G. W; et al. Cardiotrophin-1 increases angiotensinogen mRNA in rat cardiac myocytes through STAT3: An autocrine loop for hypertrophy. Hypertension. 2000, 35(6), 1191-6

Funamoto, 2000a: Funamoto, M; Fujio, Y; et al. Signal transducer and activator of transcription 3 is required for glycoprotein 130-mediated induction of vascular endothelial growth factor in cardiac myocytes. J Biol Chem. 2000, 275(14), 10561-6

Funamoto, 2000b: Funamoto, M; Hishinuma, S; et al. Isolation and characterization of the Murine Cardiotrophin-1 Gene: Expression and Norepinephrine-Induced Transcriptional Activation. J Moll Cell Cardiol. 2000, 32(7), 1275-1284

Garnier, 1978: Garnier, J; Osguthorpe, DJ; Robson, B. Analysis of the accuracy and implications of simple methods for predicting the secondary structure of globular proteins. J Mol Biol. 1978, 120(1), 97-120

Gerull, 2002: Gerull, B. G. Mutations of TTN, encoding the giant muscle filament titin, cause familial dilated cardiomyopathy. Nat Genet. 2002, 30 2, 01-204

Glavac, 1993: Glavac, D; Dean, M. Optimization of the single-strand conformation polymorphism (SSCP) technique for detection of point mutations. Hum Mutat. 1993, 2(5), 404-14

Grepin, 1994: Grepin, C; Dagnino, L; et al. A hormone-encoding gene identifies a pathway for cardiac but not skeletal muscle gene transcription. Mol Cell Biol. 1994, 14(5), 3115-29

Grompe, 1993: Grompe, M. The rapid detection of unknown mutations in nucleic acids. Nat Genet. 1993, 5(2), 111-7

Grunig, 1998: Grunig, E; Tasman, J. A; et al. Frequency and phenotypes of familial dilated cardiomyopathy. J Am Coll Cardiol. 1998, 31(1), 186-94

Haliassos, 1989: Haliassos, A; Chomel, J. C; et al. Modification of enzymatically amplified DNA for the detection of point mutations. Nucleic Acids Res. 1989, 17(9), 3606

Hamanaka, 2000: Hamanaka, I; Saito, Y; et al. Effects of cardiotrophin-1 on hemodynamics and endocrine function of the heart. Am J Physiol Heart Circ Physiol. 2000, 279(1), H388-96

Hefti, 1997: Hefti, M. A; Harder, B. A; et al. Signaling pathways in cardiac myocyte hypertrophy. J Mol Cell Cardiol. 1997, 29(11), 2873-92

Hibi, 1996: Hibi, M; Nakajima, K; et al. IL-6 cytokine family and signal transduction: a model of the cytokine system. J Mol Med. 1996, 74(1), 1-12

Hirota, 1999: Hirota, H; Chen, J; et al. Loss of a gp130 cardiac muscle cell survival pathway is a critical event in the onset of heart failure during biochemical stress. Cell. 1999, 97(2), 189-98

Hishinuma, 1999: Hishinuma, S; Funamoto, M; et al. Hypoxic stress induces cardiotrophin-1 expression in cardiac myocytes. Biochem Biophys Res Commun. 1999, 264(2), 436-40

Horvath, 1997: Horvath, C. M; Darnell, J. E. The state of the STAT´s: recent developments in the study of signal transduction to the nucleus. Curr Opin Cell Biol. 1997, 9(2), 233-9


[Seite 102↓]

Huang, 1997: Huang, W. Y; Liew, C. C. A conserved GATA motif in a tissue-specific DNase I hypersensitive site of the cardiac alpha-myosin heavy chain gene. Biochem J. 1 997, 325(Pt1), 47-51

Hunter, 1995: Hunter, J. J; Tanaka, N; et al. Ventricular expression of a MLC-2v-ras fusion gene induces cardiac hypertrophy and selective diastolic dysfunction in transgenic mice. J Biol Chem. 1995, 270(39), 23173-8

Ip, 1994: Ip, H. S; Wilson, D. B; et al. The GATA-4 transcription factor transactivates the cardiac muscle-specific troponin C promoter-enhancer in nonmuscle cells. Mol Cell Biol. 1994, 14(11), 7517-26

Ishikawa, 1999: Ishikawa, M; Saito, Y; et al. A heart-specifiv increase in cardiotrophin-1 gene expression precedes the establishment of ventricular hypertrophy in genetically hypertensive rats. J Hypertens. 1999, 17(6), 807-16

Jin, 1996: Jin, H; Yang, R; et al. In vivo effects of cardiotrophin-1. Cytokine. 1996, 8(12), 920-6

Jin, 1998: Jin, H; Yang, R; et al. Effects of cardiotrophin-1 on haemodynamics and cardiac function in concious rats. Cytokine. 1998, 10(1), 19-25

Jougasaki, 2000: Jougasaki, M; Tachibana, I; et al. Augmented cardiac cardiotrophin-1 in experimental congestive heart failure. Circulation. 2000, 101(1), 14-7

Jung, 1999: Jung, M; Poepping, I; et al. Investigation of a family with autosomal dominant dilated cardiomyopathy defines a novel locus on chromosome 2q14-q22. Am J Hum Genet. 1999, 65(4), 1068-77

Kajstura, 1997: Kajstura, J; Cigola, E; et al. Angiotensin II induces apoptosis of adult ventricular myocytes in vitro. J Mol Cell Cardiol. 1997, 29(3), 859-70

Kamisago, 2000: Kamisago, M; Sharma, S. D; et al. Mutations in Sarcomere Protein Genes as a Cause of Dilated Cardiomyopathy. N Engl J Med. 2000, 343(23), 1688-1696

Kass, 1994: Kass, S; MacRae, C; et al. A gene defect that causes conduction system disease and dilated cardiomyopathy maps to chromosome 1p1-1q1. Nature Genet, 1994, 7(4), 546-51

Kaye, 1992: Kaye, M. The registry of the International Society of Heart and Lung Transplantation: ninth official report-1992. J Heart Lung Transplant. 1992, 11, 599-606

Kelly, 1994: Kelly, D. P; Strauss, A. W. Inherited cardiomyopathies. N Engl J Med. 1994, 330(13), 913-9

Kelly, 1997: Kelly, R. A; Smith, T. W. Cytokines and cardiac contractile function (editorial). Circulation. 1997, 95(4), 778-81

Kiowski, 1998: Kiowski, W; Sutsch, G; et al. Endothelial control of vascular tone in chronic heart failure. J Cardiovasc Pharmacol. 1998, 32(Suppl 3), S67-73

Knight, 1999: Knight, J. C; Kwiatkowski, D. Inherited variability of tumor necrosis factor production and susceptibility to infectious disease. Proc Assoc Am Physicians. 1999, 111(4), 290-8

Knippers, 1990: Kinppers, R. P; Schäfer, K. P; Fanning, E. Molekulare Genetik, 5. neubearb. u. erw. Auflage, Stuttgart; New York; Thieme, 1990

Krajinovic, 1995: Krajinovic, M; Pinamonti, B; et al. Linkage of familial dilated cardiomyopathy to chromosome 9. Heart Muscle Disease Study Group. Am J Hum Genet. 1995, 57(4), 846-52

Kunisada, 2000: Kunisada, K; Negoro, S; et al. Signal transducer and activator of transcription 3 in the heart transduces not only a hypertrophic signal but a protective signal against doxorubicin-induced cardiomyopathy. Proc Natl Acad Sci U S A. 2000, 97(1), 315-9

Kuo, 1997: Kuo, C. T; Morrisey, E. E; et al. GATA4 transcription factor is required for ventral morphogenesis and heart tube formation. Genes Dev. 1997, 11(8), 1048-60

Kuwahara, 1999: Kuwahara, K; Saito, Y; et al.. Involvement of cardiotrophin-1 in cardiac myocyte-nonmyocyte interactions during hypertrophy of rat cardiac myocytes in vitro. Circulation. 1999, 100(10), S.1116-24,

Kuwahara, 2000: Kuwahara, K; Saito, Y; et al.. Cardiotrophin-1 phosphorylates akt and BAD, and prolongs cell survival via a PI3K-dependent pathway in cardiac myocytes. J Mol Cell Cardiol. 2000, 32(8), S.1385-94,

Lankford, 1995: Lankford, E. B; Epstein, N. D; et al.. Abnormal contractile properties of muscle fibers expressing beta-myosin heavy chain gene mutations in patients with hypertrophic cardiomyopathy. J Clin Invest. 1995, 95(3), S.1409-14,

Laverriere, 1994: Laverriere, A. C; MacNeill, C; et al.. GATA-4/5/6, a subfamily of three transcription factors transcribed in developing heart and gut. J Biol Chem. 1994, 269(37), S.23177-84,

Levine, 1990: Levine, B; Kalman, J; et al.. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med. 1990, 323(4), S.236-41,

Lewin, 2000: Lewin, B. Genes. Oxford University press, 2000

Li, 1999: Li, D; Tapscoft, T; et al.. Desmin mutation responsible for idiopathic dilated cardiomyopathy. Circulation. 1999, 100(5), S.461-4,

Liautard, 1997: Liautard, J; Sun R. X; et al.. Specific inhibition of IL-6 signalling with monoclonal antibodies against the gp130 receptor. Cytokine. 1997, 9(4), S.233-41,

Maisch, 1998: Maisch, B. Classification of cardiomyopathies according to the WHO/ISFC Task Force-more questions than answers?. Med Klin. 1998, 93(4), S.199-209,

Maron, 1995: Maron, BJ; Gardin, MJ; et al.. Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Circulation. 1995, 92, S.785-789,

Mathur, 1999: Mathur, A; Sims, H. F; et al.. Molecular heterogeneity in very-long-chain acyl-CoA dehydrogenase deficiency causing pediatric cardiomyopathy and sudden death. Circulation. 1999, 99(10), S.1337-43,

Matsui, 1999: Matsui, H; Ihara, Y; et al.. Induction of interleukin (IL)-6 by hypoxia is mediated by nuclear factor (NF)-kappa B and NF-IL6 in cardiac myocytes. Cardiovasc Res. 1999, 42(1), S.104-12,

Matsumori, 1994: Matsumori, A; Yamada, T; et al.. Increased circulating cytokines in patients with myocarditis and cardiomyopathy. Br Heart J. 1994, 72(6), S.561-6,

Messina, 1997: Messina, D. N; Speer, M. C; et al.. Linkage of familial dilated cardiomyopathy with conduction defect and muscular dystrophy to chromosome 6q23. Am J Hum Genet. 1997, 61(4), S.909-17,

Mestroni, 1990: Mestroni, L; Miani, D; et al.. Clinical and pathologic study of familial dilated cardiomyopathy. Am J Cardiol. 1990, 65(22), S.1449-53,

Michels, 1992: Michels, V. V; Moll, P. P; et al.. The frequency of familial dilated cardiomyopathy in a series of patients with idiopathic dilated cardiomyopathy. N Engl J Med. 1992, 326(2), S.77-82,

Middleton, 2000: Middleton, G; Hamanoue, M; et al.. Cytokin-induced nuclear factor kappa B activation promotes the survival of developing neurons. J Cell Biol . 2000, 148(2), S.325-32,

Mogensen, 1999: Mogensen, J; Klausen, I. C; et al.. Alpha-cardiac actin is a novel disease gene in familial hypertrophic cardiomyopathy. J Clin Invest. 1999, 103(10), S.R39-43,

Mogensen, 2003: Mogensen, J; Kubo, T. Idiopathic restrictive cardiomyopathy is part of the clinical expression of cardiac troponin I mutation. J Clin Invest. 2003, 111, S.209-216,

Molvig, 1988: Molvig, J; Baek, L; et al.. Endotoxin-stimulated human monocyte secretion of interleukin 1, tumor necrosis factor alpha, and prostaglandin E2 shows stable interindividual differences. Scand J Immunol. 1988, 27(6), S.705-16,

Mosley, 1996: Mosley, B; De Imus, C; et al.. Dual Oncostatin M (OSM) Receptors. Cloning and characterization of an alternative signaling subunit conferring osm-specific receptor activation. J Biol Chem. 1996, 271(50), S.32635-43,

Muesch, 1990: Muesch, A; Hartmann, E; et al.. A novel pathway for secretory proteins?. Trends Biochem Sci. 1990, 15(3), S.86-8,

Munger, 1996: Munger, M. A.; Johnson, B; et al.. Circulating concentrations of proinflammatory cytokines in mild or moderate heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol. 1996, 77(9), S.723-7,

Narula, 1996: Narula, J; Haider, N; et al.. Apoptosis in myocytes in end-stage heart failure. N Engl J Med. 1996, 335(16), S.1182-9,

Nathan, 1991: Nathan, C; Sporn, M. Cytokines in context. J Cell Biol. 1991, 113(5), S.981-6,

Negoro, 2000: Negoro, S; Kunisada, K; et al.. Activation of JAK/STAT pathway transduces cytoprotective signal in rat acute myocardial infarction. Cardiovasc Res. 2000, 47(4), S.797-805,

Neumann, 1982: Neumann, E; Schaefer-Ridder, M; et al.. Gene transfer into mouse lyoma cells by electroporation in high electric fields. Embo J. 1982, 1(7), S.841-5,

Olivetti, 1997: Olivetti, G; Abbi, R; et al.. Apoptosis in the failing human heart. N Engl J Med. 1997, 336(16), S.1131-41,

Olson, 1996: Olson, T. M; Keating, M. T. Mapping a cardiomyopathy locus to chromosome 3p22-p25. J Clin Invest. 1996, 97(2), S.528-32,

Olson, 1998: Olson, T. M; Michels, V. V; et al.. Actin mutations in dilated cardiomyopathy, a heritable form of heart failure. Science. 1998, 280(5364), S.750-2,

Olson, 2001: Olson, T. M; Kishimoto, N. Y; et al.. Mutations that alter the surface charge of alpha-tropomyosin are associated with dilated cardiomyopathy. J Mol Cell Cardiol. 2001, 33(4), S.723-732,

Orita, 1989: Orita, M; Suzuki, Y; et al.. Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction. Genomics. 1989, 5(4), S.874-9,

Pan, 1998: Pan, J; Fukuda, K; et al.. Involvement of gp130-mediated signaling in pressure overload-induced activation of the JAK/STAT pathway in rodent heart. Heart Vessels. 1998, 13(4), S.199-208,

Pan, 1999: Pan, J; Fukuda, K; et al.. Mechanical stretch activates the JAK/STAT pathway in rat cardiomyocytes. Circ Res. 1999, 84(10), S.1127-36,

Passarge, 1994: Passarge, E. Taschenbuch der Genetik. Stuttgart, New York, Thieme, 1994

Patel, 2000: Patel, R; Lim, D. S; et al.. Variants of trophic factors and expression of cardiac hypertrophy in patients with hypertrophic cardiomyopathy. J Mol Cell Cardiol. 2000, 32(12), S.2369-77,

Pennica, 1995a: Pennica, D; King, K. L; et al.. Expression cloning of cardiotrophin-1, a cytokine that induces cardiac myocyte hypertrophy. Proc Natl Acad Sci U S A. 1995, 92(4), S.1142-6,

Pennica, 1995b: Pennica, D; Shaw, K. J; et al.. Cardiotrophin-1. Biological activities and binding to the leukemia inhibitory factor receptor/gp130 signaling complex. J Biol Chem. 1995, 270(18), S.10915-22,

Pennica, 1996a: Pennica, D; Arce, V; et al.. Cardiotrophin-1, a cytokine present in embryonic muscle, supports long-term survival of spinal motoneurons. Neuron. 1996, 17(1), S.63-74,

Pennica, 1996b: Pennica, D; Swanson, T. A; et al.. Human cardiotrophin-1: protein and gene structure, biological and binding activities, and chromosomal localization. Cytokine. 1996, 8(3), S.183-9,

Peters, 1995: Peters, M; Roeb, M; et al.. A new hepatocyte stimulating factor: cardiotrophin-1 (CT-1). FEBS Lett. 1995, 372(2-3), S.177-80,

Reed, 1974: Reed, L. J. Multienzyme complexes. Acc. Chem. Res.. 1974, 7, S.40-46,

Richards, 1996: Richards, C. D; Langdon, C; et al.. Murine cardiotrophin-1 stimulates the acute-phase response in rat hepatocytes and H35 hepatoma cells. J Interferon and Cytokine Res. 1996, 16, S.69-75,

Richards, 2000: Richards, C. D; Langdon, C; et al.. Stimulation of osteoclast diffentiation in vitro by mouse oncostatin m, leukemia inhibitory factor, CARDIOTROPHIN-1 and interleukin 6: synergy with dexamethasone. Cytokine. 2000, 12(6), S.613-21,

Richardson, 1996: Richardson, P; McKenna, W; et al.. Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies. Circulation. 1996, 93(5), S.841-2,

Risch, 1996: Risch, N; Merikangas, K. The future of genetic studies of complex human diseases. Science. 1996, 273(5281), S.1516-7,

Robinson, 1994: Robinson, R. C; Grey, L. M; et al.. The crystal structure and biological function of leukemia inhibitory factor: implication for receptor binding. Cell. 1994, 77(7), S.1101-16,

Robledo, 1997: Robledo, O; Fourcin, M; et al.. Signaling of the cardiotrophin-1 receptor. Evidence for a third receptor component. J Biol Chem. 1997, 272(8), S.4855-63,

Rolfs, 1992: Rolfs, A. S. PCR: clinical diagnostics and research. Berlin, Springer Verlag, 1992

Saiki, 1986: Saiki, RK; Bugawan, TL; et al.. Analysis of enzymatically amplified beta-globin and HLA_DQ alpha DNA with allele-specific oligonucleotide probes. Nature. 1986, 324(6093), S.163-166,

Sakamoto, 1997: Sakamoto, A; Ono, K; et al.. Both hypertrophic and dilated cardiomyopathies are caused by mutation of the same gene, delta-sarcoglycan, in hamster: an animal model of disrupted Dystrophin-associated glycoprotein complex. Proc Natl Acad Sci U S A. 1997, 94(25), S.13873-8,

Sanger, 1977: Sanger, F; Nicklen, S; et al.. DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A. 1977, 74(12), S.5463-7,

Sano, 2000: Sano, M; Fukuda, K; et al.. Interleukin-6 family of cytokines mediate angiotensin II-induced cardiac hypertrophy in rodent cardiomyocytes. J Biol Chem. 2000,

Saraste, 1997: Saraste, A; Pulkki, K; et al.. Apoptosis in human acute myocardial infarction. Circulation. 1997, 95(2), S.320-3,

Schonberger, 2000: Schonberger, J; Levy, H; et al.. Dilated cardiomyopathy and sensorineural hearing loss: a heritable syndrome that maps to 6q23-24 . Circulation. 2000, 101(15), S.1812-8,

Sheng, 1996: Sheng, Z; Pennica, D; et al.. Cardiotrophin-1 displays early expression in the murine heart tube and promotes cardiac myocyte survival. Development. 1996, 122(2), S.419-28,

Sheng, 1997: Sheng, Z; Knowlton, K; et al.. Cardiotrophin 1 (CT-1) inhibition of cardiac myocyte apoptosis via a mitogen-activated protein kinase-dependent pathway. Divergence from downstream CT-1 signals for myocardial cell hypertrophy. J Biol Chem. 1997, 272(9), S.5783-91,

Shuman, 1994: Shuman, S. Novel approach to molecular cloning and polynucleotide synthesis using vaccinia DNA topoisomerase. J Biol Chem. 1994, 269(51), S.32678-84,

Simpson, 1997: Simpson, R. J; Hammacher, A; et al.. Interleukin-6: structure-function relationships. Protein Sci. 1997, 6(5), S.929-55,

Siu, 1999: Siu, B. L; Niimura, H; et al.. Familial dilated cardiomyopathy locus maps to chromosome 2q31. Circulation. 1999, 99(8), S.1022-6,

Solway, 1998: Solway, J; Forsythe, S. M; et al.. Transcriptional regulation of smooth muscle contractile apparatus expression. Am J Respir Crit Care Med. 1998, 158(5 Pt 3), S.S100-8,

Stephanou, 1998: Stephanou, A; Brar, B; et al.. Cardiotrophin-1 induces heat shock protein accumulation in cultured cardiac cells and protects them from stressful stimuli. J Mol Cell Cardiol. 1998, 30(4), S.849-55,

Sugrue, 1992: Sugrue, D. D; Rodeheffer, R. J; et al.. The clinical course of idiopathic dilated cardiomyopathy. A population based study. Ann Intern Med. 1992, 117(2), S.117-23,

Suomalainen, 1992: Suomalainen, A; Paetau, A; et al.. Inherited idiopathic dilated cardiomyopathy with multiple deletions of mitochondrial DNA. Lancet. 1992, 340(8831), S.1319-20,

Sylvius, 2001: Sylvius, N; Tesson, F; et al.. A new locus for autosomal dominant dilated cardiomyopathy identified on chromosome 6q12-q16. Am J Hum Genet. 2001, 68(1), S.241-246,

Taga, 1997: Taga, T; Kishimoto, T. Gp130 and the interleukin-6 family of cytokines. Annu Rev Immunol. 1997, 15, S.797-819,

Talwar, 1999: Talwar, S; Downie, P. F; et al.. An immunoluminometric assay for cardiotrophin-1: a newly identified cytokine is present in normal human plasma and is increased in heart failure. Biochem Biophys Res Commun. 1999, 261(3), S.567-71,

Talwar, 2000: Talwar, S; Squire, I. B; et al. . Elevated circulating cardiotrophin-1 in heart failure: Relationship with parameters of left ventricular systolic dysfunction. Clin Sci (Colch). 2000, 99(1), S.83-88,

Timmermann, 2000: Timmermann, A; Pflanz, S; et al.. Different epitopes are required for gp130 activation by interleukin-6, oncostatin M and leukemia inhibitory factor. FEBS Lett. 2000, 468(2-3), S.120-4,

Touw, 2000: Touw, I. P; De Koning, J. P; et al.. Signaling mechanisms of cytokine receptors and their perturbances in disease. Mol Cell Endocrinol. 2000, 160(1-2), S.1-9,

Tsubata, 2000: Tsubata, S; Bowles, K. R; et al.. Mutations in the delta-sarcoglycan gene familial and sporadic dilated cardiomyopathy. J Clin Invest. 2000, 106(5), S.655-662,

Ungerer, 1993: Ungerer, M; Bohm, M; et al.. Altered expression of beta-adrenergic receptor kinase and beta 1-adrenergic receptors in the failing human heart. Circulation. 1993, 87(2), S.454-63,

Vanderheyden, 1998: Vanderheyden, M; Kersschot, E; et al.. Pro-inflammatory cytokines and endothelium-dependent vasodilation in the forearm. Serial assessment in patients with congestive heart failure. Eur Heart J. 1998, 19(5), S.747-52,

Vergeer, 2000: Vergeer, W. P; Sogo, J. M; et al.. Interaction of AP1, AP2, and SP1 with the regulatory regions of the human pro-alpha1(I) collagen gene. Arch Biochem Biophys. 2000, 377(1), S.69-79,

Vosberg, 1998: Vosberg, H. P. Genetic causes of hypertrophic cardiomyopathy. Med Klin. 1998, 93(4), S.252-9,

Wallrath; 1994: Wallrath, L. L; Lu, Q; et al.. Architectural variations of the inducible eukaryotic promoters: preset and remodeling chromatin structures. Bioessays. 1994, 16(3), S.165-70,

Walton, 1990: Walton, K. M; Rehfuss, R. P. Molecular mechanisms of cAMP-regulated gene expression. Mol Neurobiol. 1990, 4(3-4), S.197-210,

Wegner, 2000: Wegner, M. Transcriptional control in myelinating glia: flavors and spices. Glia. 2000, 31(1), S.1-14,

Westendorp, 1997: Westendorp, R. G; Langermans, J. A; et al.. Genetic influence on cytokine production and fatal meningococcal disease. Lancet. 1997, 349(9046), S.170-3,

Wijdenes, 1995: Wijdenes, J; Heinrich, P. C; et al.. Interleukin-6 signal transducer gp130 has specific bindinf sites for different cytokines as determined by antagonistic and agonistic anti-gp130 monoclonal antibodies. Eur J Immunol. 1995, 25(12), S.3474-81,

Wingender, 1997: Wingender, E; Kel, A. E; et al.. TRANSFAC, TRRD and COMPEL: towards a federated database system on transcriptional regulation. Nucleic Acids Res. 1997, 25(1), S.265-8,

Wollert, 1996: Wollert, K. C; Taga, T; et al.. Cardiotrophin-1 activates a distinct form of cardiac muscle cell hypertrophy. Assembly of sarcomeric units in series via gp130/leukemia inhibitory factor receptor-dependent pathways. J Biol Chem. 1996, 271(16), S.9535-45,

Wollert, 1997: Wollert, K. C; Chien, K. R. Cardiotrophin-1 and the role of gp130-dependent signaling pathways in cardiac growth and development. J Mol Med. 1997, 75, S.492-501,

Wu, 1997: Wu, C. F; Bishopric, N. H; et al.. Atrial natriuretic peptide induces apoptosis in neonatal rat cardiac myocytes. J Biol Chem. 1997, 272(23), S.14860-6,

Yoshida, 1996: Yoshida, K; Taga, T; et al.. Targeted disruption of gp130, a common signal transducer for the interleukin 6 family of cytokines, leads to myocardial and hematological disorders. Proc Natl Acad Sci U S A. 1996, 93(1), S.407-11,

Zelis, 1982: Zelis, R; Flaim, S. F. Alterations in vasomotor tone in congestive heart failure. Prog Cardiovasc Dis. 1982, 24(6), S.437-59,

Zolk, 2002: Zolk, O; Leong, L; et al.. Augmented expression of cardiotrophin-1 in failing human hearts is accompanied by diminished glycoprotein 130 receptor protein abundance. Circulation. 2002, 106, S.1442-1446,


© Die inhaltliche Zusammenstellung und Aufmachung dieser Publikation sowie die elektronische Verarbeitung sind urheberrechtlich geschützt. Jede Verwertung, die nicht ausdrücklich vom Urheberrechtsgesetz zugelassen ist, bedarf der vorherigen Zustimmung. Das gilt insbesondere für die Vervielfältigung, die Bearbeitung und Einspeicherung und Verarbeitung in elektronische Systeme.
DiML DTD Version 3.0Zertifizierter Dokumentenserver
der Humboldt-Universität zu Berlin
HTML-Version erstellt am:
03.06.2004